Estradiol vaginal cream is a localized hormone therapy specifically formulated to address genitourinary syndrome of menopause (GSM), a collection of symptoms affecting the vulva, vagina, and lower urinary tract due to estrogen deficiency. During menopause, declining estrogen levels cause significant changes to vaginal and urogenital tissues, including thinning of the vaginal walls (vaginal atrophy), decreased natural lubrication, loss of tissue elasticity, and alterations in vaginal pH. These changes create an environment that increases susceptibility to irritation, infection, and discomfort.

Vaginal estradiol works locally within vaginal tissues to restore the vaginal epithelium to a more premenopausal state. By delivering estrogen directly to the affected tissues, vaginal estradiol therapy improves tissue thickness and elasticity, enhances natural lubrication, restores healthy vaginal pH, and reduces symptoms of atrophy. Unlike systemic estrogen therapy, intravaginal estradiol is absorbed minimally into the bloodstream, making it particularly suitable for women who prefer localized treatment or who may have contraindications to systemic hormone therapy.

GSM affects approximately 50-70% of postmenopausal women and includes symptoms such as vaginal dryness, burning, itching, painful intercourse (dyspareunia), and urinary symptoms including urgency, frequency, and recurrent infections. Unlike vasomotor symptoms such as hot flashes, GSM symptoms do not improve spontaneously over time and typically worsen without treatment. Vaginal estradiol cream offers effective symptom relief while maintaining the health and function of vaginal and urogenital tissues, significantly improving quality of life and sexual function.

Estradiol vaginal cream is inserted intravaginally using a calibrated applicator, typically at bedtime to allow for optimal absorption and minimize leakage. Many women notice improvements in vaginal moisture and comfort within 2-4 weeks of beginning treatment, with continued improvement over 2-3 months as vaginal tissues regenerate, thicken, and restore normal function. Symptoms such as dryness, irritation, and discomfort during intercourse typically improve progressively with consistent use.

Initial treatment often involves more frequent dosing (such as daily application) for the first few weeks, followed by a maintenance schedule of 2-3 times weekly. Your provider will determine the appropriate regimen based on symptom severity and response to treatment. Some women may experience mild vaginal discharge or increased sensitivity during the initial treatment period as tissues begin to respond and normalize. Regular follow-up with your provider ensures optimal symptom management and allows for treatment adjustments as needed to maintain vaginal health.

Vaginal estradiol is generally well-tolerated with minimal systemic absorption when used at recommended doses. Potential side effects may include vaginal discharge, mild irritation, spotting, or breast tenderness. This product should not be used by women with a history of estrogen-dependent cancers, unexplained vaginal bleeding, active blood clots or history of stroke, or active liver disease without thorough medical evaluation. While systemic absorption is minimal with low-dose vaginal estradiol, inform your provider of all medical conditions, medications, and complete medical history. Avoid use during pregnancy or breastfeeding.